Table 1.
Characteristic | n | % |
---|---|---|
Age, years | ||
Mean ± SD | 67.9 ± 8.1 | |
Range | 50–83 | |
Sex | ||
Female | 19 | 90.5 |
Male | 2 | 9.5 |
Smoking history | ||
Never smoker | 20 | 95.2 |
Ex-light smoker | 1 | 4.8 |
Cell type | ||
Adenocarcinoma | 19 | 90.4 |
Large cell carcinoma | 1 | 4.8 |
NSCLC | 1 | 4.8 |
EGFR mutation | ||
Not done | 17 | 80.9 |
Positive | 3 | 14.3 |
Negative | 1 | 4.8 |
Stage | ||
IIIb | 8 | 38.1 |
IV | 13 | 61.9 |
ECOG performance status | ||
0 | 6 | 28.6 |
1 | 13 | 61.9 |
2 | 2 | 9.5 |
Chemotherapy between two EGFR-TKIs | ||
Yes | 8 | 38.1 |
No | 13 | 61.9 |
EGFR epidermal growth factor receptor, ECOG Eastern Cooperative Oncology Group, TKI tyrosine kinase inhibitor